PLYMOUTH MEETING, PA — Biotechnology firm INOVIO (NASDAQ: INO) announced it will release its third-quarter 2025 financial results after the market closes on Monday, November 10, followed by a live webcast and conference call at 4:30 p.m. ET to discuss results and provide a company update.
The webcast will be accessible through INOVIO’s investor relations website and will include a live Q&A session with analysts. A replay will remain available for 90 days after the event.
INOVIO develops DNA medicines designed to help the body generate its own disease-fighting immune responses. The company’s platform technology focuses on preventing and treating HPV-related diseases, cancers, and infectious diseases, using synthetic DNA sequences to direct the body to produce targeted antibodies and T cells.
As the company continues to advance its late-stage clinical programs, investors will be watching for updates on INOVIO’s DNA medicine pipeline, financial position, and strategic outlook heading into 2026.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.